Salarius: 2Q Earnings Snapshot

HOUSTON — Salarius Pharmaceuticals, Inc. (SLRX) on Wednesday reported a loss of $1.8 million in its second quarter.
The Houston-based company said it had a loss of 13 cents per share.
The biotech drug developer posted revenue of $1.2 million in the period.
In the final minutes of trading on Wednesday, the company’s shares hit $1.07. A year ago, they were trading at $5.93.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Inve